Literature DB >> 17921007

Current management of ectopic pregnancy.

Liberato V Mukul1, Stephanie B Teal.   

Abstract

Ectopic pregnancy continues to be one of the most common gynecologic emergencies and is the leading cause of pregnancy-related first-trimester death in the United States. The rate of ectopic pregnancy continues to rise because of increases in the incidences of its risk factors. However, improved modalities of early diagnosis and treatment have reduced both mortality and morbidity of this condition. In this article, the authors present an evidence-based review of the risk factors and presentation of ectopic pregnancy, including the utility of various diagnostic techniques, and compare the appropriateness and effectiveness of different therapeutic approaches.

Mesh:

Substances:

Year:  2007        PMID: 17921007     DOI: 10.1016/j.ogc.2007.07.001

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  11 in total

1.  Attenuated tubal and endometrial urocortin 1 and corticotropin-releasing hormone receptor expression in ectopic pregnancy.

Authors:  L E Borges; A W Horne; S E McDonald; J L V Shaw; P C Lourenco; F Petraglia; H O D Critchley
Journal:  Reprod Sci       Date:  2010-10-26       Impact factor: 3.060

Review 2.  Nitric oxide synthases and tubal ectopic pregnancies induced by Chlamydia infection: basic and clinical insights.

Authors:  Ruijin Shao; Sean X Zhang; Birgitta Weijdegård; Shien Zou; Emil Egecioglu; Anders Norström; Mats Brännström; Håkan Billig
Journal:  Mol Hum Reprod       Date:  2010-07-20       Impact factor: 4.025

3.  Endometrial cysteine-rich secretory protein 3 is inhibited by human chorionic gonadotrophin, and is increased in the decidua of tubal ectopic pregnancy.

Authors:  A W Horne; W C Duncan; A E King; S Burgess; P C Lourenco; P Cornes; P Ghazal; A R Williams; L Udby; H O D Critchley
Journal:  Mol Hum Reprod       Date:  2009-03-12       Impact factor: 4.025

4.  Predictors of Success of a Single-Dose Methotrexate in the Treatment of Ectopic Pregnancy.

Authors:  Mohamed Akhatim Alsammani; Neimat Abdalhadi Moona
Journal:  J Obstet Gynaecol India       Date:  2015-01-31

5.  Diagnosis and management of ectopic pregnancy.

Authors:  Vanitha N Sivalingam; W Colin Duncan; Emma Kirk; Lucy A Shephard; Andrew W Horne
Journal:  J Fam Plann Reprod Health Care       Date:  2011-07-04

6.  The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy.

Authors:  Emma Garcia Grau; Miguel Ángel Checa Vizcaíno; Mário Oliveira; Judith Lleberia Juanós; Ramon Carreras Collado; Yolanda Canet Estevez
Journal:  Obstet Gynecol Int       Date:  2011-09-27

7.  Comparison of Two Different Protocols of Methotrexate Therapy in Medical Management of Ectopic Pregnancy.

Authors:  Najmieh Saadati; Mahin Najafian; Sara Masihi; Sara Safiary; Parvin Abedi
Journal:  Iran Red Crescent Med J       Date:  2015-12-13       Impact factor: 0.611

8.  CB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancy.

Authors:  Andrew W Horne; John A Phillips; Nicole Kane; Paula C Lourenco; Sarah E McDonald; Alistair R W Williams; Carlos Simon; Sudhansu K Dey; Hilary O D Critchley
Journal:  PLoS One       Date:  2008-12-18       Impact factor: 3.240

9.  Ectopic pregnancy: a life-threatening gynecological emergency.

Authors:  Osaheni L Lawani; Okechukwu B Anozie; Paul O Ezeonu
Journal:  Int J Womens Health       Date:  2013-08-19

10.  Fertility outcome after treatment of unruptured ectopic pregnancy with two different methotrexate protocols.

Authors:  Afsar Tabatabaii Bafghi; Fatemah Zaretezerjani; Leila Sekhavat; Raziah Dehghani Firouzabadi; Zeynab Ramazankhani
Journal:  Int J Fertil Steril       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.